Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 13/20 | 0.45 |
| ▸ | OPRK1 | P41145 | 10/20 | 0.41 |
| ▸ | ARG1 | P05089 | 1/20 | 0.40 |
| ▸ | ARG2 | P78540 | 1/20 | 0.40 |
| ▸ | LTA4H | P09960 | 1/20 | 0.39 |
| ▸ | OPRM1 | P35372 | 6/20 | 0.38 |
| ▸ | OPRD1 | P41143 | 4/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30833233 | 0.90 | KCNH2 (0.56) | KCNH2OPRK1OPRM1OPRD1 | |
| SCHEMBL30833198 | 0.80 | OPRK1 (0.47) | KCNH2OPRK1LTA4HOPRM1OPRD1 | |
| SCHEMBL30833213 | 0.70 | OPRK1 (0.48) | KCNH2OPRK1LTA4HOPRM1OPRD1 | |
| SCHEMBL30833209 | 0.70 | OPRK1 (0.56) | KCNH2OPRK1LTA4HOPRM1OPRD1 | |
| SCHEMBL30833216 | 0.70 | KCNH2 (0.58) | KCNH2OPRK1OPRM1OPRD1 | |
| SCHEMBL30833227 | 0.68 | OPRM1 (0.48) | KCNH2OPRK1LTA4HOPRM1OPRD1 | |
| SCHEMBL11098039 | 0.68 | LTA4H (0.52) | ARG1ARG2LTA4HMEN1KMT2A | |
| SCHEMBL3871503 | 0.67 | LTA4H (0.52) | KCNH2OPRK1ARG1ARG2LTA4H | |
| SCHEMBL3881484 | 0.67 | DRD2 (0.48) | ARG1ARG2LTA4HMEN1KMT2A | |
| SCHEMBL3881487 | 0.67 | DRD2 (0.48) | ARG1ARG2LTA4HMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117729914-A | Serotonin 5-HT2B inhibiting compounds | 硕腾服务有限责任公司 | 2024-03-19 | — | — | CN | disclosed |